{"id":521896,"title":"Consultation of Draft Guidance Documents: Identifying and Labelling Medicinal Ingredients, Generic Drug Equivalence: Medicinal Ingredients - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-08","captureTimestamp":"2026-03-08T17:45:01.350000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence.html","snippet":"Consultation of Draft Guidance Documents: Identifying and Labelling Medicinal Ingredients, Generic Drug Equivalence: Medicinal Ingredients Current status: Closed This consultation ran from April 8, 2019 to June 17, 2019. Health Canada is proposing amendments to the Food and Drug…","rawSnapshotUrl":"/api/snapshots/raw/521896","browseUrl":"https://replay.healtharchive.ca/job-6/20260308174501/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence.html#ha_snapshot=521896","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}